Correlation between RICTOR overexpression and amplification in advanced solid tumors

Heejin Bang1, Soomin Ahn2, Eun Ji Kim3

  • 1Department of Pathology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea; Center of Companion Diagnostics, Samsung Medical Center, Seoul, Republic of Korea.

Insights

Immunohistochemistry (IHC) can screen for Rapamycin-insensitive companion of mTOR (RICTOR) amplification in solid tumors. This method identifies heterogeneous RICTOR overexpression, a common finding, and correlates well with fluorescence in situ hybridization (FISH) results.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Rapamycin-insensitive companion of mTOR (RICTOR) is crucial for cell proliferation and survival.
  • RICTOR amplification is a potential therapeutic target in advanced solid cancers.
  • Accurate diagnostic methods for RICTOR amplification beyond next-generation sequencing are needed.

Purpose of the Study:

  • To evaluate immunohistochemistry (IHC) as a diagnostic tool for detecting RICTOR amplification in solid tumors.
  • To assess the prevalence and heterogeneity of RICTOR overexpression in a large cohort of solid tumors.
  • To correlate IHC findings with fluorescence in situ hybridization (FISH) results for RICTOR amplification.

Main Methods:

  • Immunohistochemistry (IHC) was performed on 435 solid tumor tissues.
  • Fluorescence in situ hybridization (FISH) was used to confirm RICTOR amplification in selected IHC-positive and negative cases.
  • Statistical analysis was used to compare IHC and FISH results and assess correlations.

Main Results:

  • RICTOR overexpression was detected in 49.0% of the 435 solid tumors analyzed.
  • Heterogeneous RICTOR overexpression was observed in 32.4% of IHC-positive cases.
  • FISH confirmed RICTOR amplification in 75.7% of RICTOR-overexpressed cases and 7.7% of IHC-negative cases, showing good correlation with IHC (r=0.60).

Conclusions:

  • Heterogeneous RICTOR overexpression is common in various solid tumors.
  • IHC is a reliable screening tool for identifying RICTOR amplification, especially in cases with heterogeneous expression.
  • RICTOR IHC can guide further diagnostic testing for RICTOR amplification in advanced solid cancers.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K